FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2015/12/006450 [Registered on: 21/12/2015] Trial Registered Retrospectively
Last Modified On: 04/09/2015
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   observational 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Sedation for gastrointestinal endoscopies in children 
Scientific Title of Study   Comparison of Propofol-Ketamine combination versus Sevoflurane sedation for gastrointestinal endoscopies in children 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
IEC/05/14  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vanya Chugh 
Designation  Registrar, Fellow in Paediatric Anaesthesia 
Affiliation  Lokmanya Tilak Municipal Medical College and General Hospital  
Address  Lokmanya tilak Municipal Medical College and General Hospital Department of anaesthesia, Sion, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400022
India 
Phone  9999977026  
Fax    
Email  vanya.shibu@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Anila Malde 
Designation  Professor, Department of Anaesthesia 
Affiliation  Lokmanya Tilak Municipal Medical College and General Hospital  
Address  Lokmanya tilak Municipal Medical College and General Hospital Department of anaesthesia, Sion, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400022
India 
Phone  9821085730  
Fax    
Email  dradmalde@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  vanya chugh 
Designation  Registrar, Fellow in Paediatric Anaesthesia 
Affiliation  Lokmanya Tilak Municipal Medical College and General Hospital  
Address  Lokmanya tilak Municipal Medical College and General Hospital Department of anaesthesia, Sion, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400022
India 
Phone  9999977026  
Fax    
Email  vanya.shibu@gmail.com  
 
Source of Monetary or Material Support  
Lokmanya tilak Municipal Medical College and General Hospital , Sion, Mumbai. 400022 
 
Primary Sponsor  
Name  Vanya Chugh 
Address  Lokmanya tilak Municipal Medical College and General Hospital Department of anaesthesia, Sion, Mumbai, Maharashtra 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vanya Chugh  Lokmanya tilak Municipal Medical College and General Hospital   Gastrointestinal endoscopy procedure room and paediatric surgery OT,Lokmanya tilak Municipal Medical College and General Hospital
Mumbai
MAHARASHTRA 
9999977026

vanya.shibu@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
lokmanya tilak Municipal Medical College and General Hospital staff and research society   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Paediatric patients for gastrointestinal endoscopies,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Propofol Ketamine Combination  0.5 mg/kg IV Ketamine and 1mg/kg IV propofol as loading dose followed by incremental doses of 0.25-0.5mg/kg IV propofol alone for sedation during gastrointestinal endoscopy  
Intervention  Sevoflurane  Sevoflurane at 4% dial concentration in O2:N2O mixture(50:50) to begin with, followed by mixture of O2 in sevoflurane at 1-2% dial concentration for sedation during gastrointestinal endoscopy 
 
Inclusion Criteria  
Age From  6.00 Month(s)
Age To  18.00 Year(s)
Gender  Both 
Details  Patients undergoing elective upper or lower GI endoscopic procedures.
American Society of Anaesthesiologists class I & II (I: healthy; II: single, controlled disease state).
Parents and guardians of the patient consenting for the procedure.
 
 
ExclusionCriteria 
Details  a. American Society of Anaesthesiologists class III and above.
b. Known hypersensitivity to propofol or ketamine or sevoflurane or h/s/o egg allergy.
c. Patients with following conditions:
i. Airway related problems.
ii. Respiratory disorders.
iii. Cardiovascular disorders.
iv. Central nervous system disorders/neurologic impairment.
v. Acute febrile illness.
vi. Bleeding oesophageal varices.

d. History of recent hepatitis
e. Renal insufficiency
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Time to emergence from procedural sedation
 
1) Emergence time - From end of procedure till achievement of Modified Ramsay Sedation Score ≤ 3.
2) Time to respond to light painful stimulus
3) Time to cough
4) Time to spontaneous eye opening
5) Time to achievement of purposeful limb movements
6) Time to child becoming oriented (older children)
 
 
Secondary Outcome  
Outcome  TimePoints 
1) Effectiveness of sedation in terms of Induction time, success of Induction, success of maintenance
2) Safety in terms of occurrence of complications 
•Induction time: Administration of study drugs to fixation of eyeballs, adequate jaw relaxation and Modified Ramsay Sedation Score 4 or 5.
•Success of Induction: Induction doses sufficient to allow easy passage of endoscope. Need of changeover from one group to the other will be considered as failure.
•Success of maintenance: Maintenance doses sufficient to carry out the procedure. Need of changeover from one group to the other will be considered as failure.
 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/04/2014 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Introduction: Gastrointestinal (GI) Endoscopy is a well-established procedure done for both diagnostic and therapeutic purposes. Mild sedation is adequate for adults being subjected to endoscopies but it becomes difficult to obtain cooperation from a child undergoing the same. Multiple studies have been done to develop the ideal method for procedural sedation in children. Though both propofol-ketamine combination and sevoflurane have been widely used for procedural sedation, there are no trials comparing the two of them. Hence, this observational study has been planned to compare the efficacy and safety from intravenous propofol-ketamine with inhalational sevoflurane for procedural sedation in paediatric GI endoscopies.

Aim: To evaluate and compare the efficacy and safety of intravenous propofol-ketamine versus Inhalational sevoflurane for deep sedation in paediatric GI endoscopic procedures.

Objectives: To observe following parameters in patients subjected for GI endoscopy under deep sedation with either intravenous propofol-ketamine or inhalational sevoflurane:

1)    Effectiveness in terms of: Induction time, effectiveness of agents for induction (insertion of endoscope), effectiveness of agents for maintenance, endoscopist’s comfort with agents used.

2)  Safety: Occurrence of complications like respiratory, haemodynamic fluctuations, need for restraint, use of additional anaesthetic agents, conversion to tracheal tube general anaesthesia

3)    Emergence and recovery: In terms of degree of sedation, time to recovery,post procedure agitation score, post procedure nausea vomiting.

Methodology: All the patients are premedicated, under controlled environment, in the endoscopy suite with oral Midazolam 0.5 mg/kg dose, 30 minutes prior to entry to the procedure room. In the operating room, patients in IV group receive Ketamine-Propofol (Group KP) 0.5 mg/kg IV ketamine and 1mg/kg IV propofol as loading dose followed by incremental doses of 0.25-0.5mg/kg IV propofol alone as per the requirement. We will observe for adequacy of loading dose as fixation of eyeballs and adequate jaw relaxation for scope insertion.Patients in inhalational group receive Sevoflurane (Group S) at 4% dial concentration in O2:N2O mixture(50:50) to begin with. Adequacy of sedation will be fixation of eyeballs and adequate jaw relaxation for the scope insertion. Sedation is maintained using a mixture of O2 in sevoflurane at 1-2% dial concentration with endoscopy mask.

Primary outome measure:  Recovery from sedation

Secondary outcome measures: effectiveness of sedation, occurrence of complications.

Statistical Analysis: Parametric data will be presented as mean ± standard deviation data and analyzed using unpaired t test. Repeated measurements data will be analyzed using paired t test and binary data will be analyzed using Chi-square test. Nonparametric data will be analyzed using Mann Whitney U test.

Lacuna In Existing Knowledge: Numerous agents have been used for procedural sedation for GI endoscopy. However, there is lack of consensus regarding the most suitable technique.. Using this study, an attempt is being made to determine an effective and safe technique for GI endoscopic procedural sedation in children.

 
Close